147 related articles for article (PubMed ID: 6157454)
1. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
Emson PC; Arregui A; Clement-Jones V; Sandberg BE; Rossor M
Brain Res; 1980 Oct; 199(1):147-60. PubMed ID: 6157454
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
Grafe MR; Forno LS; Eng LF
J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
[TBL] [Abstract][Full Text] [Related]
5. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
Pioro EP; Hughes JT; Cuello AC
Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary.
Gramsch C; Höllt V; Mehraein P; Pasi A; Herz A
Brain Res; 1979 Aug; 171(2):261-70. PubMed ID: 466443
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical substrates of rigidity and chorea in Huntington's disease.
Storey E; Beal MF
Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
[TBL] [Abstract][Full Text] [Related]
9. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions.
Marksteiner J; Saria A; Kirchmair R; Pycha R; Benesch H; Fischer-Colbrie R; Haring C; Maier H; Ransmayr G
Eur J Neurosci; 1993 Dec; 5(12):1573-85. PubMed ID: 7510203
[TBL] [Abstract][Full Text] [Related]
10. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
Dawbarn D; Zamir N; Waters CM; Hunt SP; Emson PC; Brownstein MJ
Brain Res; 1986 Apr; 372(1):155-8. PubMed ID: 2871898
[TBL] [Abstract][Full Text] [Related]
11. Degradation of met-enkephalin by extracts of various regions of the human brain: effects of antipsychotics and narcotics in vitro.
Jakubovic A
Peptides; 1982; 3(1):21-6. PubMed ID: 6123112
[TBL] [Abstract][Full Text] [Related]
12. Huntington's disease: changes in tachykinin content in postmortem brains.
Arai H; Emson PC; Carrasco LH
Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
[TBL] [Abstract][Full Text] [Related]
13. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
Albin RL; Reiner A; Anderson KD; Dure LS; Handelin B; Balfour R; Whetsell WO; Penney JB; Young AB
Ann Neurol; 1992 Apr; 31(4):425-30. PubMed ID: 1375014
[TBL] [Abstract][Full Text] [Related]
14. Localization of methionine-enkephalin, substance P, and somatostatin immunoreactivities in the main olfactory bulb of the hamster.
Davis BJ; Burd GD; Macrides F
J Comp Neurol; 1982 Feb; 204(4):377-83. PubMed ID: 6174555
[TBL] [Abstract][Full Text] [Related]
15. In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus.
Bayon A; Rossier J; Mauss A; Bloom FE; Iversen LL; Ling N; Guillemin R
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3503-6. PubMed ID: 277953
[TBL] [Abstract][Full Text] [Related]
16. Presence of somatostatin, enkephalins, and substance P-like peptides in cultured neurons from embryonic chick cerebral hemispheres.
Louis JC; Rougeot C; Bepoldin O; Vulliez B; Mandel P; Dray F
J Neurochem; 1983 Oct; 41(4):930-8. PubMed ID: 6194258
[TBL] [Abstract][Full Text] [Related]
17. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
Augood SJ; Faull RL; Love DR; Emson PC
Neuroscience; 1996 Jun; 72(4):1023-36. PubMed ID: 8735227
[TBL] [Abstract][Full Text] [Related]
18. Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex.
Taquet H; Javoy-Agid F; Mauborgne A; Benoliel JJ; Agid Y; Legrand JC; Tramu G; Cesselin F; Hamon M
Neuroscience; 1988 Dec; 27(3):871-83. PubMed ID: 2472575
[TBL] [Abstract][Full Text] [Related]
19. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
Buck SH; Burks TF; Brown MR; Yamamura HI
Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
[TBL] [Abstract][Full Text] [Related]
20. Co-occurrence of substance P-like and Leu-enkephalin-like immunoreactivities in neurones and fibres of avian nervous system.
Erichsen JT; Reiner A; Karten HJ
Nature; 1982 Feb; 295(5848):407-10. PubMed ID: 6173764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
